These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18602239)
1. Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Hu Q; Wang W; Zhong X; Yuan S; Fu Z; Guo H; Yu J Eur J Radiol; 2009 May; 70(2):320-4. PubMed ID: 18602239 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related]
3. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Yuan S; Yu Y; Chao KS; Fu Z; Yin Y; Liu T; Chen S; Yang X; Yang G; Guo H; Yu J J Nucl Med; 2006 Aug; 47(8):1255-9. PubMed ID: 16883002 [TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma. Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941 [TBL] [Abstract][Full Text] [Related]
5. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET]. Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018 [TBL] [Abstract][Full Text] [Related]
6. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer]. Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053 [TBL] [Abstract][Full Text] [Related]
8. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Nishiyama Y; Yamamoto Y; Kimura N; Ishikawa S; Sasakawa Y; Ohkawa M Ann Nucl Med; 2008 May; 22(4):245-50. PubMed ID: 18535874 [TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus. Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788 [TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
11. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. Choi JY; Lee KH; Shim YM; Lee KS; Kim JJ; Kim SE; Kim BT J Nucl Med; 2000 May; 41(5):808-15. PubMed ID: 10809196 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nishiyama Y; Yamamoto Y; Monden T; Sasakawa Y; Tsutsui K; Wakabayashi H; Ohkawa M Nucl Med Commun; 2005 Oct; 26(10):895-901. PubMed ID: 16160649 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma. Yasuda T; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Doki Y Ann Surg Oncol; 2015 Aug; 22(8):2599-607. PubMed ID: 25524011 [TBL] [Abstract][Full Text] [Related]
14. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma? Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053 [TBL] [Abstract][Full Text] [Related]
15. Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma. Ela Bella AJ; Zhang YR; Fan W; Luo KJ; Rong TH; Lin P; Yang H; Fu JH Chin J Cancer; 2014 Apr; 33(4):211-7. PubMed ID: 24559853 [TBL] [Abstract][Full Text] [Related]
16. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma]. Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642 [TBL] [Abstract][Full Text] [Related]
17. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Hsu WH; Hsu PK; Wang SJ; Lin KH; Huang CS; Hsieh CC; Wu YC Ann Thorac Surg; 2009 May; 87(5):1564-8. PubMed ID: 19379906 [TBL] [Abstract][Full Text] [Related]
19. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer]. Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286 [TBL] [Abstract][Full Text] [Related]
20. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]